Residential College | false |
Status | 已發表Published |
Preparation of Fe3O4@SW-MIL-101-NH2 for selective pre-concentration of chlorogenic acid metabolites in rat plasma, urine, and feces samples | |
Yin, Shi Jun1; Zhou, Xi1; Peng, Li Jing1; Li, Fang2; Zheng, Guo Can2; Yang, Feng Qing1; Hu, Yuan Jia3 | |
2022-08 | |
Source Publication | Journal of Pharmaceutical Analysis |
ISSN | 2095-1779 |
Volume | 12Issue:4Pages:617-626 |
Abstract | An innovative sandwich-structural Fe-based metal-organic framework magnetic material (FeO@SW-MIL-101-NH) was fabricated using a facile solvothermal method. The characteristic properties of the material were investigated by field emission scanning electron microscopy, transmission electron microscopy (TEM), energy-dispersive X-ray spectroscopy, Fourier transform infrared spectroscopy, X-ray powder diffraction, vibrating sample magnetometry, and Brunauer-Emmett-Teller measurements. FeO@SW-MIL-101-NH is associated with advantages, such as robust magnetic properties, high specific surface area, and satisfactory storage stability, as well as good selective recognition ability for chlorogenic acid (CA) and its metabolites via chelation, hydrogen bonding, and π-interaction. The results of the static adsorption experiment indicated that FeO@SW-MIL-101-NH possessed a high adsorption capacity toward CA and its isomers, cryptochlorogenic acid (CCA) and neochlorogenic acid (NCA), and the adsorption behaviors were fitted using the Langmuir adsorption isotherm model. Then, a strategy using magnetic solid-phase extraction (MSPE) and ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF MS) was developed and successfully employed for the selective pre-concentration and rapid identification of CA metabolites in rat plasma, urine, and feces samples. This work presents a prospective strategy for the synthesis of magnetic adsorbents and the high-efficiency pretreatment of CA metabolites. |
Keyword | Chlorogenic Acid Magnetic Solid-phase Extraction Metabolic Pathway Metal-organic Framework Sandwich Structure |
DOI | 10.1016/j.jpha.2022.01.002 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Pharmacology & Pharmacy |
WOS Subject | Pharmacology & Pharmacy |
WOS ID | WOS:000862894700010 |
Scopus ID | 2-s2.0-85134160249 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | THE STATE KEY LABORATORY OF QUALITY RESEARCH IN CHINESE MEDICINE (UNIVERSITY OF MACAU) Institute of Chinese Medical Sciences DEPARTMENT OF PUBLIC HEALTH AND MEDICINAL ADMINISTRATION |
Corresponding Author | Yang, Feng Qing; Hu, Yuan Jia |
Affiliation | 1.Department of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering, Chongqing University, Chongqing, 401331, China 2.Analytical and Testing Center, Chongqing University, Chongqing, 401331, China 3.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China |
Corresponding Author Affilication | Institute of Chinese Medical Sciences |
Recommended Citation GB/T 7714 | Yin, Shi Jun,Zhou, Xi,Peng, Li Jing,et al. Preparation of Fe3O4@SW-MIL-101-NH2 for selective pre-concentration of chlorogenic acid metabolites in rat plasma, urine, and feces samples[J]. Journal of Pharmaceutical Analysis, 2022, 12(4), 617-626. |
APA | Yin, Shi Jun., Zhou, Xi., Peng, Li Jing., Li, Fang., Zheng, Guo Can., Yang, Feng Qing., & Hu, Yuan Jia (2022). Preparation of Fe3O4@SW-MIL-101-NH2 for selective pre-concentration of chlorogenic acid metabolites in rat plasma, urine, and feces samples. Journal of Pharmaceutical Analysis, 12(4), 617-626. |
MLA | Yin, Shi Jun,et al."Preparation of Fe3O4@SW-MIL-101-NH2 for selective pre-concentration of chlorogenic acid metabolites in rat plasma, urine, and feces samples".Journal of Pharmaceutical Analysis 12.4(2022):617-626. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment